Advertisement

Topics

EMERGENT TECHNOLOGIES, INC Company Profile

00:52 EDT 24th September 2017 | BioPortfolio

Our unique process matches breakthrough technology developed at Universities or Research Institutions with commercialization partners who validate the technology and the market potential, thus reducing risk and accelerating the technology to market. We establish and manage companies that hold exclusive licenses and rights to technology that has had significant research funding and that is ready to be commercialized. Our value add is to form partnerships with large international companies pursuing major markets and managing the development process to bring the technology, products and services to market in a timely manner

Location

2508 Ashley Worth Blvd.Suite 200

Austin
Texas
78738
United States of America

Contact

Phone: 512) 263-3232
Fax: 512) 263-3236
Email: info@emergenttechnologies.com


News Articles [493 Associated News Articles listed on BioPortfolio]

Emergent BioSolutions embarks on another spending spree

Shares of US biotech firm Emergent BioSolutions closed up 3.3% at $36.04 yesterday, after it announced…

Emergent BioSolutions to acquire anthrax treatment, move manufacturing to Baltimore

Emergent BioSolutions, a Gaithersburg-based drug maker with facilities in Baltimore, has acquired a drug used to treat anthrax from GlaxoSmithKline in a deal worth up to $96 million. Under the deal an...

GSK's raxibacumab acquired by Emergent for $76M upfront

GlaxoSmithKline granted Emergent BioSolutions rights to regulatory approvals and intellectual property rights for its FDA-app -More- 

Emergent Biosolutions (EBS) versus Theravance Biopharma (TBPHV) Head to Head Contrast

Theravance Biopharma and Emergent Biosolutions are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownershi...

Emergent BioSolutions buying rights to smallpox vaccine

Emergent BioSolutions has entered into an agreement to acquire the ACAM2000 (Smallpox [Vaccinia] Vaccine,…

Emergent BioSolutions to buy GSK’s anthrax treatment raxibacumab

Emergent BioSolutions has agreed to acquire GlaxoSmithKline’s (GSK) anthrax monoclonal antibody, raxibacumab, for around $96m.

Emergent BioSolutions To Buy ACAM2000 Business From Sanofi For Up To $125 Mln

PARIS (dpa-AFX) - Emergent BioSolutions Inc. (EBS) Friday announced that it has entered into an agreement to acquire the ACAM2000, (Smallpox (Vaccinia) Vaccine, Live) business of Sanofi (SNYNF, SN...

Emergent to buy Sanofi smallpox vaccine and take on CDC contract

Emergent BioSolutions will pay up to $125m (€108m) for Sanofi’s smallpox vaccine ACAM2000 in a deal that includes a plant and 10-year supply contract with the US Government.

PubMed Articles [559 Associated PubMed Articles listed on BioPortfolio]

Mortality Following Emergent Trauma Laparotomy: a Multicenter, Retrospective Study: Mortality after Emergent Trauma Laparotomy.

Two decades ago, hypotensive trauma patients requiring emergent laparotomy had a 40% mortality. In the interim, multiple interventions to decrease hemorrhage-related mortality have been implemented bu...

Telehealth and eHealth interventions for posttraumatic stress disorder.

This paper presents existing research describing how telehealth and eHealth technologies can be used to improve mental health services for trauma survivors, either by enhancing existing treatment appr...

What can Parents' Self-report of Reading Difficulties Tell Us about Their Children's Emergent Literacy at School Entry?

Research has linked family risk (FR) of reading difficulties (RD) with children's difficulties in emergent literacy development. This study is the first to apply parents' self-report of RD as a proxy ...

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Clinical Trials [420 Associated Clinical Trials listed on BioPortfolio]

Multifactorial Approach to Emergent Cerclage

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is ...

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

The investigators aim to retrospectively map the delays in the acute care of traumatic brain injury patients necessitating emergent craniotomies.

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when d...

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPCC is used to reverse the eff...

Cardiovascular Events in Patients With CAD During Emergent Endoscopy for Upper Gastrointestinal Bleeding

Background: Upper gastrointestinal (GI) bleeding, a common disorder encountered at emergency room, may cause hypotension and tachycardia that may in turn result in myocardial ischemia in ...

Companies [1241 Associated Companies listed on BioPortfolio]

Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, E...

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Emergent Financial Group, Inc.

Emergent Financial Group provides investment banking services for early stage growth companies in healthcare. By specializing on innovative healthcare companies, Emergent has deve...

Emergent Technologies, Inc.

Headquartered in Austin, Texas, Emergent Technologies, Inc. (Emergent) is a leading innovation solutions company that identifies, manages, develops and partners to turn game-chang...

Virtual Radiologic Corp.

Virtual Radiologic Corporation (vRad) is a national radiology practice working in partnership with local radiologists and hospitals to optimize radiology’s pivotal role in pa...

More Information about "EMERGENT TECHNOLOGIES, INC" on BioPortfolio

We have published hundreds of EMERGENT TECHNOLOGIES, INC news stories on BioPortfolio along with dozens of EMERGENT TECHNOLOGIES, INC Clinical Trials and PubMed Articles about EMERGENT TECHNOLOGIES, INC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EMERGENT TECHNOLOGIES, INC Companies in our database. You can also find out about relevant EMERGENT TECHNOLOGIES, INC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record